Examining the Therapeutic Potential of Stem Cell Derived Microglia

Описание к видео Examining the Therapeutic Potential of Stem Cell Derived Microglia

Mathew Blurton-Jones presents CRISPR-based interventions for a rare brain disorder in mice by substituting defective brain cells with healthy ones. He details experiments demonstrating the efficacy of corrected cells in mitigating brain pathologies. Blurton-Jones emphasizes the need for cautious translation to human trials, advocating gradual cell replacement to preempt potential adverse effects. Additionally, he delves into the implications of microglia in Alzheimer's disease progression and explores potential interconnections among various neurodegenerative conditions. [2/2024] [Show ID: 38333]

Donate to UCTV to support informative & inspiring programming:
https://www.uctv.tv/donate

Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.

More from: Breaking News in Stem Cells: Southern California Stem Cell Seminar Series
(https://www.uctv.tv/stem-cell/stem-ce...)

More from: Stem Cell Channel
(https://www.uctv.tv/stem-cell)

Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.

UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)

Комментарии

Информация по комментариям в разработке